Fri, January 5, 2024
Thu, January 4, 2024
Wed, January 3, 2024
Tue, January 2, 2024
Fri, December 29, 2023
Thu, December 28, 2023
Wed, December 27, 2023
Tue, December 26, 2023
Fri, December 22, 2023

Uy Ear Upgraded (ARQT) to Strong Buy and Increased Target to $8 on, Jan 3rd, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. y-and-increased-target-to-8-on-jan-3rd-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Uy Ear of Mizuho, Upgraded "Arcutis Biotherapeutics, Inc." (ARQT) to Strong Buy and Increased Target from $4 to $8 on, Jan 3rd, 2024.

Uy has made no other calls on ARQT in the last 4 months.



There are 4 other peers that have a rating on ARQT. Out of the 4 peers that are also analyzing ARQT, 2 agree with Uy's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Sean Kim of "JonesTrading" Downgraded from Strong Buy to Hold on, Wednesday, November 8th, 2023
  • Jonathan Block of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $6 on, Friday, October 13th, 2023


These are the ratings of the 2 analyists that currently disagree with Uy


  • Nigel Dally of "Morgan Stanley" Maintained at Buy with Decreased Target to $10 on, Monday, November 13th, 2023
  • Serge Belanger of "Needham" Maintained at Strong Buy with Decreased Target to $8 on, Monday, November 6th, 2023

Publication Contributing Sources